Research Journals

AACN ADVANCED CRITICAL CARE (list date 8/23/17)AAS OPEN RESEARCH (list date 3/18/19)ABCS HEALTH SCIENCES (list date 12/1/15)ABDOMEN (list date 10/28/15)ACADEMIA ANATOMICA INTERNATIONAL (list date 2/18/16)ACADEMIC EMERGENCY MEDICINE (list date 3/20/14)ACADEMIC FORENSIC PATHOLOGY: THE OFFICIAL PUBLICATION OF…

Continue ReadingResearch Journals
Read more about the article Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy.
Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy.

Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy.

Dickkopf-related protein 2 (DKK2)is a member of the Dickkopf household in Wnt signaling pathway. Recently, we discovered that antibodies against DKK2 might activate pure killer (NK) and CD8+ T cells…

Continue ReadingRational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy.
Read more about the article Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.
Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.

Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.

Operable gastrointestinal cancers proceed to pose vital challenges. Radical resections are hardly ever healing, and chemotherapy is ready to cut back tumor recurrence for solely a small proportion of patients.…

Continue ReadingTargeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.
Read more about the article Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.

SARS-CoV-2-caused COVID-19 instances are rising globally, calling for growing efficient therapeutics to regulate the present pandemic. SARS-CoV-2 and SARS-CoV acknowledge angiotensin-converting enzyme 2 (ACE2) receptor through the receptor-binding area (RBD).…

Continue ReadingIdentification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.

Mybiosource Polyclonal Antibodies

Find Polyclonal Antibodies from Mybiosource at Gentaur. Submit your order to info@gentaur.com. CatNamePrice18-AAP-330EBIM/BOD Polyclonal Antibody345 €544-MBS9203127C1QL3 Polyclonal Antibody270 €18-SPA-865FCalnexin Polyclonal Antibody425 €18-KAP-ST010ECasein Kinase 2 Polyclonal Antibody322 €544-MBS8242077CD115 CSF1R Polyclonal Antibody369 €544-MBS926116CD14…

Continue ReadingMybiosource Polyclonal Antibodies